Background
==========

Lung cancer is one of the most common cancers and is a leading cause of cancer death in China. It was estimated that by year 2025, more than one million Chinese will be diagnosed with lung cancer per year \[[@B1]\]. Lung cancer mortality increased 465% during the past 30 years and now is the leading cancer death cause in China \[[@B2]\]. Smoking is regarded as the most important risk factor for lung cancer, and indoor air pollution from cooking and heating is another potential risk factor in Chinese population \[[@B3]\]. However, approximately one in ten lifetime smokers develop lung cancer, which implies a possible role for genetic susceptibility in the development of lung cancer \[[@B4]\].

The *TP53* tumor suppressor gene plays a critical role in modulating transcription of genes that govern the major defenses against tumor growth, including cell cycle arrest, apoptosis, maintenance of genetic integrity, inhibition of angiogenesis and cellular senescence \[[@B5]\]. The *TP53* gene harbors high-frequency, functional single-nucleotide polymorphisms (SNPs) which may alter P53 protein function \[[@B6]\]. Several functional *TP53* SNPs have been reported to be associated with risk of developing different human cancers, including lung cancer \[[@B7]-[@B9]\].

*TP53* rs2078486 SNP was recently identified to be associated with lung cancer risk in lifetime never smokers in a pathway-based genotyping study which evaluated a comprehensive panel of 11,737 SNPs in inflammatory-pathway genes \[[@B10]\]. One case--control study conducted among 611 lung cancer cases and 1040 controls in Los Angeles found elevated lung cancer risk associated with the variant genotype of *TP53* rs2078486 SNP (doctoral dissertation from Yi Ren Wang) \[[@B11]\]. However this association was not confirmed by another pooled genome-wide association study \[[@B12]\]. In addition to lung cancer, *TP53* rs2078486 SNP has been also linked with risk of ovarian cancer \[[@B13]\] and schizophrenia \[[@B14]\]. To our knowledge, no case--control study has been conducted in the Asian population to replicate the association of *TP53* rs2078486 SNP with lung cancer.

The most studied *TP53* SNP rs1042522 is characterized by substitution of Arginine (Arg) by Proline (Pro) at codon 72 (G12139C, Arg72Pro) and may noticeably affect P53 function \[[@B15]\]. However, very few studies examined if there are interactions between Arg72Pro polymorphism and smoking or other lifestyle factors on lung cancer risk.

A case--control study was conducted to examine the associations of *TP53* rs2078486 and rs1042522 SNPs with lung cancer risk in a Chinese population and further explore their interactions with some demographic and lifestyle factors.

Methods
=======

Study participants
------------------

A case--control study was conducted between 2005 and 2007 in Taiyuan city, the capital of Shanxi province, China. The original study population has been described in detail previously \[[@B16]\]. Prior to the initiation of the recruitment, IRB approvals were obtained from Fudan University (IRB\#04-10-0022) and UCLA (IRB\#11-003153), respectively. Lung cancer cases were enrolled from the Shanxi tumor hospital, which admitted about 70% of the cancer patients from the city. Eligible cases were newly diagnosed lung cancer cases, 20 years of age or older, lived in Taiyuan city for 10 years or more, in stable medical condition and willing to participate. Controls were randomly selected from 13 communities in Taiyuan city. Eligible controls were 20 years of age or older, must have lived in Taiyuan city for 10 years or more, and had no history of cancer or any other serious chronic diseases. A total of 399 lung cancer patients and 466 healthy controls were recruited to participate in this study. Response rates were 89% for eligible cases and 85% for eligible controls. Written informed consent was obtained from all study participants.

Data collection
---------------

All cases and controls were interviewed by professional staff to collect information on demographic factors, dietary and cooking habits, active and passive smoking history, alcohol drinking habits, tea drinking habits, residence and housing history, occupational history and related exposure, physical activities and disease history.

Blood sample collection and laboratory analysis of gene polymorphisms
---------------------------------------------------------------------

Blood samples were collected from 97.9% of cases and 98.9% of controls. Serum and blood clot were immediately separated and all samples were stored in freezer at −80°C. Genomic DNA was extracted using a modified phenol-chloroform protocol. Genotyping was performed in the Molecular Epidemiology Laboratory at Department of Epidemiology, School of Public Health at UCLA. *TP53* SNP genotyping was performed using Sequenom platform (Sequenom, Inc., San Diego, CA). Polymerase chain reaction (PCR) and extension primers were designed using MassARRAY Assay Design 3.1 software (Sequenom, Inc., San Diego, CA). Genotyping procedures were performed according to the manufacturer's iPLEX Application Guide (Sequenom Inc. SanDiego,CA). For quality control, we included two negative controls (H~2~O) in each 96-well plate. Around 4.5% of samples were selected for duplication and the concordance is 99.5%. We found no obvious deviations from Hardy-Weinberg equilibrium for both SNPs (rs2078486: χ^2^ = 0.19, P = 0.6629; rs1042522: χ^2^ = 4.24, P = 0.0395) among control subjects. We did not find strong linkage disequilibrium between the two SNPs (D' \< 0.5) in the current study and this is consistent with previous studies \[[@B17],[@B18]\].

Definition of indoor air pollution index
----------------------------------------

An indoor air pollution index was created to integrate the impacts from different types of cooking and heating fuels, use of ventilator in kitchen, windows opening behaviors and secondhand smoke exposure at home on indoor air pollution levels. For each component of this index, a score of '0′ or '1′ represented low or high indoor air pollution, respectively. A summarized score lower than 2 was defined as low indoor air pollution exposure and higher or equal to 2 was defined as high indoor air pollution exposure \[[@B16]\].

Statistical analysis
--------------------

Odds ratios (ORs) and 95% confidence intervals (95% CIs) were estimated using unconditional logistic regression models to evaluate the independent effects of the two *TP53* SNPs. We presented each of the associations in additive, dominant and recessive models, respectively. Potential confounding factors adjusted in the multivariate models included age, education level, annual personal income 10 years ago, pack-years of smoking, alcohol drinking and tea drinking status. Stratified analyses were conducted among subgroups with different age, gender, smoking status, alcohol and tea drinking status, indoor air pollution exposure and histo-pathological types of lung cancer. Multiplicative interactions of *TP53* SNPs with some lifestyle factors were assessed using ORs for interactions by including their product terms in the logistic regression models. Additive interactions were assessed using relative excess risk due to interaction (RERI), as described previously \[[@B19]\]. All statistical analyses were performed using SAS software (version 9.3). Associations were considered statistically significant if the p-value \< 0.05 in the two-sided test.

Results
=======

Basic characteristics of lung cancer cases and controls are presented in Table [1](#T1){ref-type="table"}. No statistically significant differences in age and gender were found between cases and controls. Controls tended to have higher education levels, average annual income and body mass index than cases (p \< 0.0001). Lung cancer cases were more likely to be smokers and had higher pack-years of smoking, but were less likely to be current tea drinkers (p \< 0.0001) (Table [1](#T1){ref-type="table"}).

###### 

Basic characteristics of cases and controls in Taiyuan lung cancer study

  **Variable**                       **Cases**    **Controls**   **P value**
  --------------------------------- ------------ -------------- -------------
  **Age**                                                              
    ≤ 45 years                       59 (14.8)     83 (17.8)       0.0725
    45 -- 55 yrs                     96 (24.1)     139 (29.8)   
    55 -- 65 yrs                     111 (27.8)    116 (25.0)   
    \> 65 yrs                        133 (33.3)    128 (27.4)   
  **Gender**                                                           
    Male                             202 (50.6)    234 (50.2)      0.9038
    Female                           197 (49.4)    232 (49.8)   
  **Education**                                                        
    Illiterate                       43 (10.8)      23 (4.9)     **\<.0001**
    Primary school                   106 (26.6)    81 (17.4)    
    Junior middle school             124 (31.1)    175 (37.5)   
    Senior middle school             68 (17.0)     120 (25.8)   
    College or higher                58 (14.5)     67 (14.4)    
  **Pack years of smoking**                                            
    Non smokers                      179 (44.9)    285 (61.2)    **\<.0001**
    \< 20 pyrs                        39 (9.8)     62 (13.3)    
    20 -- 40 pyrs                    64 (16.0)     72 (15.5)    
    ≥ 40 pyrs                        117 (29.3)    47 (10.1)    
  **Average income 10 years ago**                                      
    \< 1,000 yuan                    104 (26.1)    106 (22.7)    **\<.0001**
    1,000 -- 2,500 yuan              236 (59.1)    197 (42.3)   
    ≥ 2,500 yuan                     59 (14.8)     163 (35.0)   
  **BMI (kg/m**^**2**^**)**                                            
    \< 18.5                           22 (5.8)      9 (2.0)      **\<.0001**
    18.5 -- 24.9                     250 (66.3)    259 (56.3)   
    25 -- 29.9                       90 (23.9)     162 (35.2)   
    ≥ 30                              15 (4.0)      30 (6.5)    
  **Alcohol drinking**                                                 
    No                               298 (74.7)    345 (74.0)      0.8267
    Yes                              101 (25.3)    121 (26.0)   
  **Tea drinking**                                                     
    No                               242 (60.6)    263 (56.5)    **\<.0001**
    Previous drinkers                47 (11.8)      15 (3.2)    
    Current drinkers                 110 (27.6)    188 (40.3)   
  **Total**                             399           466              

Adjusted age, gender, education, pack years of smoking, alcohol drinking, tea drinking and average income 10 years ago.

Significant differences were highlighted in bold.

Table [2](#T2){ref-type="table"} presents the independent associations between the two *TP53* SNPs and lung cancer risk in the total study population. No significant associations with lung cancer risk were found for *TP53* rs2078486 SNP, despite a tendency towards an elevated lung cancer risk associated with the variant genotype. A significantly increased lung cancer risk was observed among individuals with the homozygous variant genotype (CC) of *TP53* SNP rs1042522 (adjusted OR: 1.63, 95% CI: 1.10 - 2.41), compared with the homozygous wild type (GG). Adjusted ORs for rs1042522 were also statistically significant in the recessive model (adjusted OR: 1.57, 95% CI: 1.11- 2.21), but not in the dominant model. C allele of *TP53* SNP rs1042522 was significantly associated with increased risk of developing lung cancer (adjusted OR: 1.26, 95% CI: 1.04 - 1.53) (Table [2](#T2){ref-type="table"}).

###### 

**Associations of*TP53*SNPs with lung cancer risk in Taiyuan lung cancer study in total study population**

         **SNP**         **Genotype**   **Cases**   **Controls**   **Crude OR (95% CI)**   **Adjusted OR\* (95% CI)**                          
  --------------------- -------------- ----------- -------------- ----------------------- ---------------------------- ----------------------- -----------------------
   ***TP53*rs2078486**                     355                              448                                                                            
                              CC           186          52.4                250                       55.8                        1                       1
                              TC           136          38.3                167                       37.3                1.10 (0.82, 1.47)       1.20 (0.88, 1.64)
                              TT           33           9.3                 31                        6.9                 1.43 (0.85, 2.42)       1.30 (0.75, 2.25)
     Dominant model      Any T vs. CC      169          47.6                198                       44.2                1.15 (0.87, 1.52)       1.22 (0.91, 1.63)
     Recessive model     TT vs. Any C      33           9.3                 31                        6.9                 1.38 (0.83, 2.30)       1.20 (0.70, 2.06)
        Allele OR          T vs. C                                                                                        1.15 (0.93, 1.43)       1.17 (0.93, 1.46)
   ***TP53*rs1042522**                     363                              446                                                                            
                              GG           118          32.5                161                       36.1                        1                       1
                              CG           146          40.2                196                       43.9                1.02 (0.74, 1.40)       1.07 (0.77, 1.50)
                              CC           99           27.3                89                        20.0              **1.52 (1.05, 2.20)**   **1.63 (1.10, 2.41)**
     Dominant model      Any C vs. GG      245          67.5                285                       63.9                1.17 (0.88, 1.57)       1.24 (0.92, 1.69)
     Recessive model     CC vs. Any G      99           27.3                89                        20.0              **1.50 (1.08, 2.09)**   **1.57 (1.11, 2.21)**
        Allele OR          C vs. G                                                                                      **1.21 (1.01, 1.46)**   **1.26 (1.04, 1.53)**

\*Adjusted for age, gender, education, pack years of smoking, alcohol drinking, tea drinking and average income 10 years ago.

Significant results were highlighted in bold.

Results from the stratified analyses are presented in Figure [1](#F1){ref-type="fig"}. Presence of one or both copies of minor allele (TC or CC) of *TP53* rs2078486 SNP was significantly or borderline significantly associated with elevated lung cancer risk among older individuals (adjusted OR: 1.53, 95% CI: 0.97 - 2.41), smokers (adjusted OR: 1.70, 95% CI: 1.08 - 2.67), alcohol drinkers (adjusted OR: 2.41, 95% CI: 1.25 - 4.65) and individuals with high indoor air pollution exposure (adjusted OR: 1.51, 95% CI: 1.00-2.30) (Figure [1](#F1){ref-type="fig"}). Significant multiplicative and additive interactions were found between the indoor air pollution index and *TP53* rs2078486 polymorphism (adjusted OR for interaction: 1.89, 95% CI: 1.00-3.56, adjusted REPI: 0.90, 95% CI: 0.11-1.70). There was also some suggestive evidence of multiplicative interaction between smoking and *TP53* rs2078486 polymorphism (adjusted OR for interaction: 1.80, 95% CI: 0.99-3.30) and additive interaction (adjusted RERI: 2.49, 95% CI: -0.03, 5.01) (Table [3](#T3){ref-type="table"}).

![**Associations of*TP53*rs2078486 with lung cancer among different subgroups with different age, gender, smoking status, alcohol and tea drinking status, indoor air pollution exposure and histo-pathological types of lung cancer.** Adjusted age, gender, education, pack years of smoking, alcohol drinking, tea drinking and average income 10 years ago. AC: adenocarcinoma, SCC: squamous cell carcinoma; SmCC: small cell carcinoma. Asterisks indicate significant ORs.](1471-2407-13-607-1){#F1}

###### 

**Interaction between*TP53*SNPs and lifestyle factors in Taiyuan lung cancer study**

                                              **Cases**   **Controls**   **Crude OR (95% CI)**   **Adjusted OR\* (95% CI)**
  -------------------------- --------------- ----------- -------------- ----------------------- ----------------------------
  **Smoking**                 **rs2078486**                                                                   
    No                             CC            95           147                  1                         1
    No                          TC or TT         70           127          0.85 (0.58, 1.26)         0.93 (0.62, 1.39)
    Yes                            CC            91           103          1.37 (0.93, 2.00)       **3.58 (2.02, 6.36)**
    Yes                         TC or TT         99            71        **2.16 (1.45, 3.22)**     **6.00 (3.33, 10.81)**
    OR for interaction                                                   **1.85 (1.05, 3.27)**       1.80 (0.99, 3.30)
    RERI                                                                 **0.94 (0.14, 1.74)**       2.49 (−0.03, 5.01)
  **Alcohol drinking**        **rs2078486**                                                                   
    No                             CC            147          184                  1                         1
    No                          TC or TT         124          148          1.05 (0.76, 1.45)         1.06 (0.76, 1.48)
    Yes                            CC            39            66          0.74 (0.47, 1.16)         0.71 (0.42, 1.21)
    Yes                         TC or TT         45            50          1.13 (0.71, 1.78)         1.35 (0.79, 2.30)
    OR for interaction                                                     1.45 (0.76, 2.78)         1.79 (0.90, 3.58)
    RERI                                                                  0.34 (−0.27, 0.95)         0.58 (−0.15, 1.30)
  **Tea drinking**            **rs2078486**                                                                   
    Yes                            CC            65           107                  1                         1
    Yes                         TC or TT         75            91          1.36 (0.88, 2.09)         1.44 (0.91, 2.28)
    No                             CC            121          143          1.39 (0.94, 2.06)         1.43 (0.92, 2.22)
    No                          TC or TT         94           107          1.45 (0.96, 2.19)         1.51 (0.94, 2.41)
    OR for interaction                                                     0.77 (0.43, 1.35)         0.73 (0.40, 1.32)
    RERI                                                                  −0.30 (−1.08, 0.48)       −0.37 (−1.21, 0.48)
  **Indoor air pollution**    **rs2078486**                                                                   
    Low                            CC            63           124                  1                         1
    Low                         TC or TT         41           105          0.77 (0.48, 1.23)         0.78 (0.48, 1.28)
    High                           CC            107          122        **1.73 (1.16, 2.57)**     **1.42 (0.92, 2.20)**
    High                        TC or TT         104           89        **2.30 (1.52, 3.48)**     **2.11 (1.35, 3.29)**
    OR for interaction                                                     1.73 (0.94, 3.18)       **1.89 (1.00, 3.56)**
    RERI                                                                  0.81 (−0.03, 1.65)       **0.90 (0.11, 1.70)**
  **Smoking**                 **rs1042522**                                                                   
    No                          GG or CG         120          216                  1                         1
    No                             CC            48            58          1.49 (0.96, 2.32)       **1.59 (1.00, 2.53)**
    Yes                         GG or CG         144          141        **1.84 (1.33, 2.54)**     **4.73 (2.78, 8.04)**
    Yes                            CC            51            31        **2.96 (1.80, 4.88)**     **8.00 (4.08, 15.71)**
    OR for interaction                                                     1.08 (0.55, 2.11)         1.07 (0.52, 2.18)
    RERI                                                                  0.63 (−0.87, 2.14)         2.69 (−1.64, 7.02)
  **Alcohol drinking**        **rs1042522**                                                                   
    No                          GG or CG         200          263                  1                         1
    No                             CC            74            69          1.41 (0.97, 2.05)         1.45 (0.98, 2.14)
    Yes                         GG or CG         64            94          0.90 (0.62, 1.29)         0.90 (0.57, 1.41)
    Yes                            CC            25            20          1.64 (0.89, 3.04)         1.86 (0.92, 3.76)
    OR for interaction                                                     1.30 (0.61, 2.80)         1.44 (0.63, 3.27)
    RERI                                                                  0.34 (−0.78, 1.45)         0.52 (−0.82, 1.86)
  **Tea drinking**            **rs1042522**                                                                   
    Yes                         GG or CG         100          159                  1                         1
    Yes                            CC            41            35        **1.86 (1.11, 3.12)**     **2.09 (1.21, 3.61)**
    No                          GG or CG         164          198          1.32 (0.95, 1.82)         1.39 (0.95, 2.04)
    No                             CC            58            54        **1.71 (1.09, 2.67)**     **1.81 (1.10, 2.97)**
    OR for interaction                                                     0.70 (0.36, 1.36)         0.62 (0.31, 1.25)
    RERI                                                                  −0.47 (−1.62, 0.68)       −0.67 (−1.99, 0.65)
  **Indoor air pollution**    **rs1042522**                                                                   
    Low                         GG or CG         73           188                  1                         1
    Low                            CC            33            41        **2.07 (1.22, 3.53)**     **1.99 (1.14, 3.48)**
    High                        GG or CG         159          163        **2.51 (1.78, 3.56)**     **2.04 (1.40, 2.99)**
    High                           CC            56            46        **3.14 (1.95, 5.04)**     **2.76 (1.66, 4.58)**
    OR for interaction                                                     0.60 (0.30, 1.21)         0.68 (0.33, 1.41)
    RERI                                                                  −0.45 (−2.14, 1.24)       −0.28 (−1.88, 1.33)

\*Adjusted for age, gender, education, pack years of smoking, alcohol drinking, tea drinking and average income 10 years ago.

Significant results were highlighted in bold.

Elevated risk of lung cancer associated with homozygous variant genotype (CC) of *TP53* SNP rs1042522 were observed in each subgroup. No obvious difference was observed between smokers and nonsmokers (Figure [2](#F2){ref-type="fig"}). The variant genotype of *TP53* SNP rs1042522 tended to confer stronger deleterious effect for younger individuals, males, alcohol and tea drinkers, however neither multiplicative nor additive interactions were observed between *TP53* SNP rs1042522 and any lifestyle factors on lung cancer risk (Table [3](#T3){ref-type="table"}).

![**Associations of*TP53*rs1042522 with lung cancer among different subgroups with different age, gender, smoking status, alcohol and tea drinking status, indoor air pollution exposure and histo-pathological types of lung cancer.** Asterisks indicate significant ORs. AC: adenocarcinoma, SCC: squamous cell carcinoma; SmCC: small cell carcinoma. Adjusted age, gender, education, pack years of smoking, alcohol drinking, tea drinking and average income 10 years ago.](1471-2407-13-607-2){#F2}

Discussion
==========

This case--control study confirmed elevated lung cancer risk associated with the variant allele (C) of *TP53* SNP rs1042522, and this study is among the first to report a tendency of increased lung cancer risk associated with variant genotype of *TP53* SNP rs2078486 in an Asian population. Moreover, we found synergetic effects of smoking and indoor air pollution exposure with TP53 SNP rs2078486 on lung cancer risk.

Overwhelming evidence suggested that the *TP53* tumor suppressor gene is a central regulatory node of multiple cellular response pathways to endogenous or exogenous stresses \[[@B20]\]. P53 protein has demonstrated the capacity to regulate activity of key effectors of cellular processes, such as DNA repair, cell cycle arrest, senescence, and apoptosis \[[@B21],[@B22]\]. Functional inactivation of P53 pathways is thought to affect P53 signaling and further alter cancer risk \[[@B20],[@B23]\].

*TP53* rs2078486 SNP might be a novel *TP53* SNP affecting risk of developing lung cancer. One pathway-based genotyping study conducted among nonsmokers found statistically significant association between *TP53* rs2078486 SNP and lung cancer \[[@B10]\]. In the present study, we found some suggestive evidence of elevated lung cancer risk associated with TC or CC genotypes of *TP53* rs2078486 SNP (adjusted OR: 1.22, 95% CI: 0.91 -1.63) in the overall study participants. Our result was in similar direction with one population-based case--control study conducted in Los Angeles (adjusted OR: 1.61, 95% CI: 1.18 -- 2.20) \[[@B11]\]. The less significant association observed in our study might relate to the relatively smaller sample size. Some other case--control studies also suggested that variant genotype of *TP53* rs2078486 SNP was significantly associated with increased risks of ovarian cancer and schizophrenia \[[@B13],[@B14],[@B24]\]. Therefore, this suggests that there might be a functional difference among different genotypes of *TP53* rs2078486 SNP, which may affect the risk of developing various types of cancers and other human diseases.

*TP53* rs2078486 is located in intron 1 and thus is not likely to be a direct disease-causing polymorphism. However previous studies suggest that *TP53* rs2078486 is in a large linkage disequilibrium block extending from upstream of exon 1 to the first half of intron 1 \[[@B17]\]. Therefore it is possible that *TP53* rs2078486 might be in linkage disequilibrium with some functional polymorphisms, which in turn alter susceptibility to human diseases. Some other intronic variations in *TP53* were reported to affect disease risk previously and the most widely studied one is *TP53* intron 3 duplication polymorphism (rs17878362) \[[@B5],[@B25]\]. The underlying mechanism by which *TP53* rs2078486 modulates cancer risk is not fully understood and warrants further investigations. However prior studies provided some initial evidence that *TP53* rs2078486 is in perfect linkage disequilibrium with *TP53* rs2287498, which is predicted to affect function at a splice site and *TP53* rs2078486 is also in weak linkage disequilibrium with *TP53* rs12951953, which might affect a transcription factor binding site \[[@B13]\].

Moreover, we found carrying the variant alleles of *TP53* rs2078486 SNP was significantly associated with elevated lung cancer risk in smokers (adjusted OR: 1.70, 95% CI: 1.08 - 2.67) and individuals with high indoor air pollution exposure (adjusted OR: 1.51, 95% CI: 1.00-2.30). Cigarette smoking and air pollution have been linked with high frequency of *TP53* mutations \[[@B26]-[@B29]\]. The positive interactions observed between *TP53* SNP rs2078486 with smoking and indoor air pollution exposure in our study might suggest that individuals carrying the variant genotype of *TP53* rs2078486 may have compromised P53 function and respond poorly to the adverse effects of smoking and air pollution, thus have an elevated risk of developing lung cancer. In addition, the elevated risk associated with high-risk genotypes *TP53* rs2078486 SNP was more evident for the small cell carcinoma, which has been more strongly linked to cigarette smoking than the other histo-pathological types of lung cancer.

Elevated lung cancer risk associated with the variant C allele of *TP53* SNP rs1042522 observed in this study was consistent with previous studies conducted among the Asian populations (summarized OR under recessive genetic model: 1.37, 95% CI: 1.20 -- 1.57; homozygote comparison CC vs. GG: 1.34, 95% CI: 1.16 -- 1.56) \[[@B8]\]. In the present study, we did not find heterogeneity of lung cancer risks associated with *TP53* SNP rs1042522 in smokers versus non-smokers, which was also consistent with a previous meta-analysis \[[@B8]\]. Very few prior studies have examined if demographic or other lifestyle factors might modify the association between *TP53* SNP rs1042522 and lung cancer. In this study, we did not find statistically significant interactions between lifestyle factors and *TP53* SNP rs1042522 on lung cancer risk.

One major limitation of the present study is that the relatively small sample size, especially in the stratified analyses, limited our ability to detect moderate interactions. Large-scale epidemiological studies are needed in the future to confirm our findings. Second, after conducting Bonferroni correction for multiple comparisons, no significant interactions between lifestyle factors and *TP53* rs2078486 SNP remained; therefore we cannot exclude the possibility of spurious associations due to multiple comparisons. Lastly, recall bias is likely for established or probable risk factors of lung cancer, such as smoking and air pollution, in a case--control study. However the association between smoking and lung cancer observed in the current study is similar to the previous studies conducted in an Asian population \[[@B30]\]. To minimize the possible recall bias on indoor air pollution exposure, we collected information on several relevant variables, such as cooking, heating and window opening behaviors.

Conclusions
===========

In conclusion, this case--control study provided preliminary evidence that *TP53* rs2078486 SNP is a novel *TP53* SNP that may affect lung cancer risk, especially among smokers and individuals with high indoor air pollution exposure. There is some further evidence of significant interactions between *TP53* rs2078486 SNP and smoking and indoor air pollution exposure on lung cancer risk. Further studies with larger sample size and in different study populations are warranted to confirm our findings.
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